Petmed Express Inc (NASDAQ:PETS) has received a consensus rating of “Hold” from the eight brokerages that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $42.80.
Several research analysts recently commented on the stock. ValuEngine upgraded shares of Petmed Express from a “hold” rating to a “buy” rating in a report on Wednesday, February 7th. Noble Financial reiterated a “hold” rating on shares of Petmed Express in a report on Friday, October 27th. BidaskClub downgraded shares of Petmed Express from a “strong-buy” rating to a “buy” rating in a report on Friday, January 19th. Finally, Northcoast Research set a $58.00 target price on shares of Petmed Express and gave the stock a “buy” rating in a report on Wednesday, January 3rd.
In other news, Director Gian Fulgoni sold 20,000 shares of the business’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $44.38, for a total transaction of $887,600.00. Following the transaction, the director now owns 55,900 shares in the company, valued at approximately $2,480,842. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Ronald J. Korn sold 5,000 shares of the business’s stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $48.38, for a total transaction of $241,900.00. Following the transaction, the director now owns 68,833 shares in the company, valued at approximately $3,330,140.54. The disclosure for this sale can be found here. Insiders sold a total of 65,000 shares of company stock worth $3,229,500 in the last quarter. Insiders own 4.00% of the company’s stock.
Several large investors have recently bought and sold shares of PETS. Sei Investments Co. increased its holdings in shares of Petmed Express by 50,142.9% during the 3rd quarter. Sei Investments Co. now owns 3,517 shares of the company’s stock worth $117,000 after purchasing an additional 3,510 shares during the period. LS Investment Advisors LLC increased its holdings in shares of Petmed Express by 283.5% during the 4th quarter. LS Investment Advisors LLC now owns 2,861 shares of the company’s stock worth $130,000 after purchasing an additional 2,115 shares during the period. Sterling Investment Advisors Ltd. increased its holdings in shares of Petmed Express by 118.5% during the 4th quarter. Sterling Investment Advisors Ltd. now owns 2,950 shares of the company’s stock worth $134,000 after purchasing an additional 1,600 shares during the period. Thompson Siegel & Walmsley LLC bought a new position in shares of Petmed Express during the 3rd quarter worth about $149,000. Finally, CenterStar Asset Management LLC bought a new position in shares of Petmed Express during the 4th quarter worth about $169,000. Institutional investors own 96.66% of the company’s stock.
Shares of Petmed Express (NASDAQ PETS) opened at $44.17 on Thursday. Petmed Express has a 52 week low of $19.21 and a 52 week high of $57.80. The stock has a market cap of $909.95, a price-to-earnings ratio of 26.14, a P/E/G ratio of 2.60 and a beta of 0.95.
Petmed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, January 22nd. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. The business had revenue of $60.10 million during the quarter, compared to analyst estimates of $56.76 million. Petmed Express had a net margin of 12.84% and a return on equity of 34.04%. Petmed Express’s quarterly revenue was up 13.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.24 EPS. equities research analysts predict that Petmed Express will post 1.7 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, February 16th. Investors of record on Monday, February 5th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.26%. The ex-dividend date of this dividend was Friday, February 2nd. This is an increase from Petmed Express’s previous quarterly dividend of $0.20. Petmed Express’s dividend payout ratio (DPR) is 59.17%.
ILLEGAL ACTIVITY NOTICE: This report was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/18/brokerages-set-petmed-express-inc-pets-price-target-at-42-80.html.
About Petmed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.